NCT07214025 Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children Status NOT_YET_RECRUITING Phase N/A
NCT07194850 A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) Status RECRUITING Phase PHASE2/PHASE3
NCT07043946 A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) Status RECRUITING Phase PHASE1/PHASE2
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05446831 Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT05281068 The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT05116423 Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia Status UNKNOWN Phase N/A
NCT04943042 An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP Status COMPLETED Phase N/A
NCT04904276 Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy Status TERMINATED Phase N/A
NCT04747080 The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04735588 Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP Status UNKNOWN Phase N/A
NCT04089267 Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE4
NCT02914054 Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone Status COMPLETED Phase PHASE2/PHASE3